Advos

Apptronik, a developer of humanoid robots, completed a $4.2 million secondary share purchase with Aegis Capital as placement agent, signaling continued investor interest in AI-powered robotics for industrial applications.

Aspermont Limited will bring together over 2,000 mining industry participants in Perth to discuss technology, energy transition, and workforce development, addressing key challenges facing the global resources sector.

Investors are shifting focus to companies supplying key components like server CPUs, high-bandwidth memory, and optical networking, viewed as bottlenecks in the AI ecosystem, following Nvidia’s GPU shortage success.

Nicola Mining Inc. is finalizing preparations to begin gold and silver extraction at its Dominion Gold Project in British Columbia, with mill feed extraction expected in early July, processing at its wholly owned Merritt Mill.

Nicola Mining Inc. is finalizing preparations to begin gold and silver extraction at its Dominion Gold Project in British Columbia, with mill feed extraction expected in early July, processing at its fully permitted Merritt Mill.

Frontieras North America Inc. introduces its FASForm platform to convert coal into fuels, hydrogen, and industrial products, addressing surging electricity demand from AI data centers.

Oncotelic Therapeutics is leveraging its Sapu003 program and Deciparticle platform to improve oncology drug delivery, aligning with a broader industry trend toward enhancing existing therapies through advanced delivery technologies.

Meta plans to pilot paid subscriptions for its AI tools, moving beyond advertising to monetize AI with premium features.

Europe's transition to renewable energy is hindered by insufficient storage infrastructure, but innovations from companies like Frontieras North America Inc. could help overcome this challenge.

As the U.S. housing market struggles with affordability and supply shortages, BOXABL is advancing factory-built, foldable homes as a scalable solution, having signed a merger agreement with FG Merger II Corp. (NASDAQ: FGMC).

The soaring electricity demand from AI data centers is accelerating interest in natural hydrogen as a clean baseload power source, with MAX Power Mining Corp. confirming North America's first subsurface natural hydrogen system and advancing commercial evaluation.

Biotechnology companies are increasingly focusing on advanced drug delivery systems to enhance the efficacy of established cancer therapies, with Oncotelic Therapeutics advancing its Sapu003 and Deciparticle platform as part of a broader industry trend toward nanotechnology-enabled delivery and AI-enhanced biomedical infras...

The SILVER Act, proposed in the U.S. House and Senate, seeks to modify regulations for vaults storing precious metals like gold, silver, and platinum, potentially impacting investors and the metals industry.

LIXTE Biotechnology Holdings shifts its focus to AI energy infrastructure, targeting power solutions for data centers, while seeking a partner for its cancer treatment assets.

BOXABL, merging with FG Merger II Corp., progresses toward Nasdaq listing under BXBL as its factory-built, foldable homes aim to address the U.S. housing shortage of over 4 million units.

Precise Business Solutions expands its managed IT services to help mid-market businesses in Houston navigate cybersecurity, cloud solutions, and IT consulting.

The American Heart Association is launching a mobile CPR unit at FIFA Fan Festivals in Atlanta, Dallas, Philadelphia, and New York/New Jersey to teach Hands-Only CPR during the global soccer tournament, aiming to double cardiac arrest survival rates by 2030.

MAX Power Mining is progressing commercial evaluation of its natural hydrogen discovery in Saskatchewan, positioning it as a scalable energy solution for AI infrastructure amid rising electricity demand.

Helus Pharma announced its participation in the Jefferies Global Healthcare Conference, highlighting its clinical-stage development of novel serotonergic agonists for mental health conditions.

Oncotelic Therapeutics (OTCQB: OTLC) reported its first-quarter 2026 financial results, maintaining the fair value of its 45% stake in GMP Biotechnology at approximately $388 million, demonstrating stability in a volatile biotech market.

Oncotelic Therapeutics Inc. reported a stable fair value of $388 million for its 45% stake in GMP Biotechnology, highlighting resilience in a volatile biotech market.